SAGA Diagnostics

SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). Our mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally invasive liquid biopsy cancer testing services and kits. With our two proprietary product platforms SAGAsafe® and SAGASign® we can help patients, healthcare professionals and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence with an unprecedented sensitivity/specificity. Web: sagadiagnostics.com Email: [email protected]